China VC Fund Invests In Israeli Life Science Startups

November 19, 2015 | The newly established Guangzhou-Israel Bio Fund, with $100 million in assets under management, will develop joint ventures between Israeli and Chinese life science companies. The fund will be led by Yehoshua Gleitman, a former Chief Scientist and will be managed by a joint Israeli-Chinese team. Its backers include the Guangzhou municipal government and three Chinese companies, among them one of the country’s biggest pharmaceutical firms. The fund said it was already investigating collaboration with five Israeli startups dealing in pharma and medical devices.